NRXP Award Disclosure
Abrams Michael S · SEC Form 4 · Filed Nov 4, 2026
Award
Calculated transaction value
$0
Abrams Michael S Chief Financial Officer
NRXP
NRX Pharmaceuticals
NRXP
Transaction date
Jul 28, 2026
Public filing date
Nov 4, 2026
Filing lag
Filed 99 days later
NRXP daily price context
Close on/before transaction
$3.54
Jul 28, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Restricted Stock Unit on Common Stock
- Quantity / price
- 75,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001437749-26-035010
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Nrx Pharmaceuticals, Inc. NRXP Current | Award | Jul 28, 2026 | $0 |